Accessing Veyonda® for Compassionate Use
Noxopharm is an Australian drug development company dedicated to the discovery and delivery of new treatments for cancer and sepsis. Our team at Noxopharm is passionate about bringing effective treatments and options to patients who need them.
Veyonda® is currently under clinical trial and is classified as an unapproved product, it is not a registered prescription medicine. Despite this, in some circumstances after careful discussion with the treating physician, Noxopharm may be able to provide Veyonda® for compassionate use on a case-by-case basis to patients in Australia.
In this situation, your physician will consider all possible benefits and risks regarding the best treatment options for you. If you would like further information, please ask your physician to contact Noxopharm Limited at: email@example.com
Veyonda® is currently not approved in Australia or any other country